Inflammatory Markers Shape EGFR-Mutant Lung Cancer
Emerging research from a leading group of scientists has shed new light on the complex interplay between systemic inflammation and ...
Tag: targeted therapy for lung cancer
Chidamide Boosts Lung Cancer Drug Sensitivity
In a remarkable new study published in BMC Cancer, researchers have uncovered how the drug chidamide—a histone deacetylase inhibitor—exerts multifaceted ...
Zidesamtinib Demonstrates Lasting Efficacy in ROS1 TKI-Pretreated NSCLC, Including Cases with CNS Involvement and ROS1 G2032R Mutations
In a groundbreaking advancement for the treatment of ROS1-positive non-small cell lung cancer (NSCLC), a novel investigational agent, zidesamtinib, has ...
Non-Coding Lung Cancer Genes Found in 13,722 Chinese
In a groundbreaking study that pushes the frontier of cancer genomics, researchers have unveiled the hidden world of non-coding genetic ...
Combining MET and EGFR Inhibitors Boosts NSCLC Treatment
In the relentless battle against non-small cell lung cancer (NSCLC), a new beacon of hope emerges through the strategic combination ...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!